Fertility And Pregnancy Rapid Test Kits Market Forecast Covering Growth Inclinations and Development Strategies Until 2027 | Leading Players -Quidel Corporation, bioMérieux SA, Yancheng Cordial Medlab Co., Ltd.

Human chorionic gonadotropin (hCG) hormone, luteinizing hormone (LH), and follicle stimulating hormone (FSH) are some of the reproductive hormones which are quantitatively detected using the tools of fertility along with pregnancy rapid test kits. In males, the detection of the sperm count can be done with the use of fertility rapid test kits. In females, the fertility rapid test kits are used to confirm menopause or to find the exact day of ovulation. Immunoassay techniques which change the color are used in these devices, the type of the device being used decides which sample should be used for the test, whether blood or urine sample, a small quantity of sample is used for the test.

Future Market Insights estimates that fertility and pregnancy rapid test kit market will experience a spike in sales in 2020, reaching US$ ~ 1.3 Bn by the year end.

Increasing incidence of gynecological disorders and infertility and fast and self-contained tests are some of the driving factors for the growth of the global fertility and pregnancy rapid test kits market. Rise in first-time pregnancy age and availability of less time-consuming decentralized diagnostic tests in place of laboratory tests have boosted the market growth. Increasing inclination toward the smartphone app connectivity, attractive product features, and technological advancements have led to the adoption of fertility and pregnancy rapid test kits. These factors are boosting the demand for these devices and the market is projected to grow significantly during the forecast period. However, the impeding growth factors in countries who have inherent potential due to which these products are not well adopted, too many options in the market being available and controversies and issues related to the devices lead to the restraints of the growing market for fertility as well as pregnancy rapid test kits.

For more insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-607

In Asia Pacific and Europe, the premier companies consolidate their position with strong local companies by maintaining distribution agreements and with e-commerce partners the strategies like creating alliances are employed in the market for fertility including pregnancy rapid test kits.

On the basis of product type, the market can be segmented as fertility rapid test kits and pregnancy rapid test kits. The pregnancy rapid test kits segment can be further classified as digital devices and line-indicator devices. The line-indicator devices includes mid-stream devices, strip/dip sticks, and cassettes. The fertility rapid test kits segment can be categorized as digital devices and line-indicators. On the basis of test type, the market can be segmented as hCG urine test, hCG blood test, FSH urine test, and LH urine test. Globally, there is a high prevalence of infertility rate and gynecological disorders leading to high demand for hCG rapid test. Based on distribution channel, the market can be segmented as fertility and gynecology clinics, hypermarkets and supermarkets, online sales, drugstores, pharmacies, and other clinics. The drugstores segment is the most preferable distribution channel, followed by the pharmacies segment. However, in some regions such as North America and Europe, these traditional distribution channels have started facing significant competition from the online sales segment due to increasing consumer preference toward online sales that provide doorstep services.

Key Takeaways of Fertility and Pregnancy Rapid Test Market Study        

• Among distribution channels segmentation, pharmacies and drug stores are expected to hold nearly 50% of the market share
• Rising age of first time pregnancy in North America is one of the major factors that drive its growth to the leading position in the market.

Geographically, the market for fertility and pregnancy rapid test kits is distributed over North America, Europe, Asia Pacific, and rest of the world. North America dominates the global market with the U.S. accounting for a considerable market share. Europe followed North America in terms of market share. The Asia Pacific and rest of the world markets are projected to expand at significant growth rate during the forecast period attributed to factors such as high unmet needs, emerging economies, and continuously improving scenario.

Get Access to Research Methodology Prepared by Experts>>>  https://www.futuremarketinsights.com/ask-question/rep-gb-607

Key Segments Covered

The global market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

By Product type

• Pregnancy Rapid Test
• Line-Indicator Devices
• Strip/Dip Sticks
• Mid-Stream
• Cassettes
• Digital
• Fertility Rapid Test
• Line-Indicator
• Digital

By Test Type

• LH Urine
• FSH Urine
• hCG Blood
• hCG Urine

Distribution Channel

• Pharmacy
• Drug Stores
• Gynecology/Fertility Clinics
• e-Commerce
• Hypermarket/Supermarket

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa (MEA)

Prominent players operating in the fertility and pregnancy rapid test kits market include Quidel Corporation; Alere Inc.; Church & Dwight Co., Inc.; Prestige Brands Holdings, Inc.; Geratherm Medical AG; bioMérieux SA; Procter & Gamble Co.; Abbott Laboratories; Swiss Precision Diagnostics GmbH; and DCC Plc.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-607

Want more insights?

Fertility and pregnancy rapid test market, a new study from Future Market Insights, opines on the fertility and pregnancy rapid test from 2015 – 2019 and presents demand projections from 2020 – 2030 on the basis of product (pregnancy rapid test (line-indicator devices (strips/dip sticks, mid-stream and cassettes) and digital devices and fertility rapid test (line-indicators and digital devices)), test type (LH urine, FSH urine, hCG blood, hCG urine), and distribution channel (pharmacies, drug stores, gynecology/fertility clinics, e-commerse and hypermarkets/supermarkets) across seven prominent regions.

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here